Tech Center 3700 • Art Units: 3735 3791
This examiner grants 50% of resolved cases
Meredith H. Weare is an examiner in Tech Center 3700, specifically Art Unit 3735. Her historical data includes 720 resolved cases. The allowance rate for Weare is 50.4 percent, which indicates a balanced prosecution environment. This rate suggests that approximately half of the applications reviewed by this examiner result in a patent grant.
The interview lift for Weare is 31.7 percent. This is a substantial lift, indicating that interviews are an effective tool for increasing the probability of allowance. Practitioners should note that while the baseline rate is 50.4 percent, the 31.7 percent lift suggests that direct verbal communication can significantly change the trajectory of an application toward a successful outcome. Scheduling an interview should be a primary tactical consideration.
The median days to allowance is 1419. This duration represents a relatively long timeline for reaching a resolution. The combination of a 1419-day median and a 50.4 percent allowance rate suggests that prosecution can be a lengthy process. However, the 31.7 percent interview lift provides a clear strategy for practitioners looking to improve their chances of success within the 720 resolved cases analyzed in Art Unit 3735.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18901467 | Determining Respiration Rates Based On Audio Streams and User Conditions | Non-Final OA | Apple Inc. |
| 17929545 | DERIVATION OF CARDIAC AND RESPIRATORY SIGNALS FROM A THERMAL CAMERA SYSTEM | Non-Final OA | Covidien LP |
| 17155671 | RESPIRATORY TREATMENT SYSTEM INCLUDING PHYSIOLOGICAL SENSORS | Final Rejection | ResMed Pty Ltd |
| 18800803 | METHODS, DEVICES AND SYSTEMS FOR ANALYTE MONITORING MANAGEMENT | Non-Final OA | Abbott Diabetes Care Inc. |
| 18656715 | SYSTEM, DEVICE AND METHOD OF DYNAMIC GLUCOSE PROFILE RESPONSE TO PHYSIOLOGICAL PARAMETERS | Final Rejection | Abbott Diabetes care Inc. |
| 18383977 | METHODS FOR ANALYTE MONITORING MANAGEMENT AND ANALYTE MEASUREMENT DATA MANAGEMENT, AND ARTICLES OF MANUFACTURE RELATED THERETO | Final Rejection | ABBOTT DIABETES CARE INC. |
| 18339787 | SYSTEMS, DEVICES, AND METHODS FOR WELLNESS AND NUTRITION MONITORING AND MANAGEMENT USING ANALYTE DATA | Non-Final OA | Abbott Diabetes Care Inc. |
| 17996537 | BLOOD PRESSURE MEASUREMENT METHOD AND APPARATUS, AND WEARABLE DEVICE | Non-Final OA | Huawei Technologies Co., Ltd. |
| 18248722 | ASSESSING A CARDIAC CONDITION INDEPENDENTLY OF PPG WAVEFORM AMPLITUDE ANALYSIS | Non-Final OA | THE JOHNS HOPKINS UNIVERSITY |
| 19034131 | GUIDE WIRE WITH SENSOR | Non-Final OA | Asahi Intecc Co., Ltd. |
| 18810015 | SENSORS FOR CONTINUOUS ANALYTE MONITORING | Non-Final OA | DexCom, Inc. |
| 17821624 | LUMEN DESIGN WITHIN INTRAVENOUS TUBE TO TRANSMIT BLOOD PRESSURE WAVE FOR INVASIVE BLOOD PRESSURE MONITORING | Final Rejection | Honeywell International Inc. |
| 18931879 | SYSTEM COORDINATOR AND MODULAR ARCHITECTURE FOR OPEN-LOOP AND CLOSED-LOOP CONTROL OF DIABETES | Non-Final OA | UNIVERSITY OF VIRGINIA PATENT FOUNDATION |
| 18333955 | SYSTEM COORDINATOR AND MODULAR ARCHITECTURE FOR OPEN-LOOP AND CLOSED-LOOP CONTROL OF DIABETES | Non-Final OA | UNIVERSITY OF VIRGINIA PATENT FOUNDATION |
| 18791154 | GAS THERAPY SYSTEM | Non-Final OA | Fisher & Paykel Healthcare Limited |
| 17671241 | INTRAVASCULAR DEVICES, SYSTEMS, AND METHODS HAVING A CORE WIRE WITH MULTIPLE FLATTENED SECTIONS | Non-Final OA | PHILIPS IMAGE GUIDED THERAPY CORPORATION |
| 18874111 | DEVICES, METHODS, AND SYSTEMS FOR COLLECTING AQUATIC FIELD METABOLIC RATE DATA | Non-Final OA | UNIVERSITY OF DELAWARE |
| 18388624 | METHOD AND APPARATUS FOR MONITORING CARDIO-PULMONARY HEALTH | Final Rejection | ResMed Sensor Technologies Limited |
| 18031668 | A COLLECTING DEVICE AND A METHOD FOR COLLECTION OF AIRBORNE PARTICLES FROM A FLOW OF AIR | Non-Final OA | IMEC VZW |
| 17939149 | CONFIGURABLE WAKE UP ALARM USING PHYSIOLOGICAL MONITORING | Non-Final OA | Whoop, Inc. |
| 16555730 | SYSTEMS AND METHODS FOR CONCURRENTLY DISPLAYING SELECTED AND UNSELECTED EEG DATA | Non-Final OA | Cadwell Laboratories, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy